4.5 Article

Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice

期刊

JOURNAL OF NEUROCHEMISTRY
卷 106, 期 3, 页码 1471-1482

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1471-4159.2008.05506.x

关键词

aminergic neurotransmission; anxiety; organic cation transporter; psychostimulants; stress

向作者/读者索取更多资源

Organic cation transporters (OCTs) are carrier-type polyspecific permeases known to participate in low-affinity extraneuronal catecholamine uptake in peripheral tissues. OCT3 is the OCT subtype most represented in the brain, yet its implication in central aminergic neurotransmission in vivo had not been directly demonstrated. In a detailed immunohistochemistry study, we show that OCT3 is expressed in aminergic pathways in the mouse brain, particularly in dopaminergic neurons of the substantia nigra compacta, non-aminergic neurons of the ventral tegmental area, substantia nigra reticulata (SNr), locus coeruleus, hippocampus and cortex. Although OCT3 was found mainly in neurons, it was also occasionally detected in astrocytes in the SNr, hippocampus and several hypothalamic nuclei. In agreement with this distribution, OCT3/Slc22a3-deficient mice show evidence of altered monoamine neurotransmission in the brain, with decreased intracellular content and increased turnover of aminergic transmitters. The behavioral characterization of these mutants reveal subtle behavioral alterations such as increased sensitivity to psychostimulants and increased levels of anxiety and stress. Altogether our data support a role of OCT3 in the homeostastic regulation of aminergic neurotransmission in the brain.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression

Alejandro Orrico-Sanchez, Laetitia Chausset-Boissarie, Rodolphe Alves de Sousa, Basile Coutens, Sara Rezai Amin, Vincent Vialou, Franck Louis, Assia Hessani, Patrick M. Dansette, Teodoro Zornoza, Carole Gruszczynski, Bruno Giros, Bruno P. Guiard, Francine Acher, Nicolas Pietrancosta, Sophie Gautron

MOLECULAR PSYCHIATRY (2020)

Article Neurosciences

LSP5-2157 a new inhibitor of vesicular glutamate transporters

Odile Poirel, Lauren E. Mamer, Melissa A. Herman, Marie Arnulf-Kempcke, Myriam Kervern, Brigitte Potier, Stephanie Miot, Jing Wang, Franck-Cyril Favre-Besse, Isabelle Brabet, Younes Laras, Hugues-Olivier Bertrand, Francine Acher, Jean-Philippe Pin, Jean-Luc Puel, Bruno Giros, Jacques Epelbaum, Christian Rosenmund, Patrick Dutar, Stephanie Daumas, Salah El Mestikawy, Nicolas Pietrancosta

NEUROPHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Regulation of GluA1 phosphorylation by d-amphetamine and methylphenidate in the cerebellum

Laura Cutando, Emma Puighermanal, Laia Castell, Pauline Tarot, Federica Bertaso, Patricia Bonnavion, Alban de Kerchove d'Exaerde, Elsa Isingrini, Micaela Galante, Glenn Dallerac, Vincent Pascoli, Christian Luescher, Bruno Giros, Emmanuel Valjent

Summary: The study found that d-amphetamine and methylphenidate can increase phosphorylation of GluA1 in the membrane fraction of the mouse cerebellum; Bergmann glial cells are the source of pS845-GluA1 and intact NE release is required; NE regulates GluA1 phosphorylation in Bergmann glial cells in response to prescription stimulants.

ADDICTION BIOLOGY (2021)

Article Neurosciences

Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors

Sanjeev K. Bhardwaj, Qiming Cui, Luc Moquin, Alain Gratton, Bruno Giros, Lalit K. Srivastava

Summary: Reduced expression of schizophrenia-associated gene DTNBP1 and its protein product dysbindin-1 in the brains of schizophrenia patients has been reported. Mouse models with DTNBP1 knockout show altered dopaminergic, glutamatergic, and GABAergic neurotransmission in cortico-limbic regions. Dysbindin-1 deficiency in dopamine neurons leads to impaired mesolimbic dopamine transmission, affecting locomotor behavior and prepulse inhibition.

NEUROPHARMACOLOGY (2021)

Article Neurosciences

Contrasting Functions of Mitogen- and Stress-activated Protein Kinases 1 and 2 in Recognition Memory and In Vivo Hippocampal Synaptic Transmission

Elise Morice, Valerie Enderlin, Sophie Gautron, Serge Laroche

Summary: The mitogen-activated protein kinases (MAPK) play a crucial role in memory consolidation, with MSK1 and MSK2 mediating signal transduction downstream of MAPK. While loss of Msk1 affects synaptic transmission and spatial recognition memory, the deletion of Msk2 does not impact these aspects. However, neither Msk1 nor Msk2 deletion affects LTP in vivo, as well as LTP-induced phosphorylation of CREB and expression of EGR1.

NEUROSCIENCE (2021)

Article Neurosciences

Astrocytes respond to a neurotoxic Aβ fragment with state-dependent Ca2+ alteration and multiphasic transmitter release

Cuong Pham, Karine Herault, Martin Oheim, Steeve Maldera, Vincent Vialou, Bruno Cauli, Dongdong Li

Summary: This study investigated astrocytic responses to the neurotoxic A beta fragment present in Alzheimer's disease patients through fluorescence imaging of signaling pathways. The results showed that A beta 25-35 induced different Ca2+ responses in astrocytes in different states, accompanied by a multiphasic release of signaling molecules.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Neurosciences

The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex

Florian Rebeillard, Stephanie De Gois, Nicolas Pietrancosta, Thi Hue Mai, Rene Lai-Kuen, Brigitte L. Kieffer, Bruno Giros, Renaud Massart, Michele Darmon, Jorge Diaz

Summary: GPR88 is highly expressed in striatal medium spiny neurons and has an atypical intranuclear localization in cortical neurons. It interacts with nuclear proteins ATRX, TOP2B, and BAZ2B involved in chromatin remodeling.

CEREBRAL CORTEX (2022)

Article Neurosciences

Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates

Amaia Nunez-delMoral, Iria Brocos-Mosquera, Vincent Vialou, Luis F. Callado, Amaia M. Erdozain

Summary: This study characterized the expression of hevin protein in adult human brain by Western blot, revealing specific immunoreactive bands with different glycosylation patterns. The study also found differences in hevin expression in various brain regions and its presence in certain diseases and physiological fluids.

NEUROSCIENCE (2021)

Editorial Material Medicine, Research & Experimental

A novel role for thrombospondins in abnormal neuroplasticity associated with behavioral disorders in adult mice

Vincent Vialou

M S-MEDECINE SCIENCES (2022)

Article Neurosciences

Disruption of Astrocyte-Dependent Dopamine Control in the Developing Medial Prefrontal Cortex Leads to Excessive Grooming in Mice

Francesco Petrelli, Tamara Zehnder, Anthony Laugeray, Sarah Mondoloni, Corrado Cali, Luca Pucci, Alicia Molinero Perez, Bianca Maria Bondiolotti, Eva De Oliveira Figueiredo, Glenn Dallerac, Nicole Deglon, Bruno Giros, Lorenzo Magrassi, Jean-Pierre Mothet, Manuel Mameli, Linda D. Simmler, Paola Bezzi

Summary: This study investigates the relationship between VMAT2 in astrocytes and the regulation of DA levels, finding that impairment of astrocytic control of DA leads to reduced DA levels, excessive grooming, and compulsive repetitive behaviors. The expression of VMAT2 in human PFC astrocytes validates the translational relevance of these findings.

BIOLOGICAL PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder

Amaia Nunez-delMoral, Paula C. Bianchi, Iria Brocos-Mosquera, Augusto Anesio, Paola Palombo, Rosana Camarini, Fabio C. Cruz, Luis F. Callado, Vincent Vialou, Amaia M. Erdozain

Summary: A protein called hevin is highly expressed in the adult brain and plays a role in stress resilience and motivated behaviors. This study found that hevin levels are elevated in the brain tissue of individuals with alcohol use disorder, and that alcohol exposure and withdrawal can alter hevin levels. Moreover, suppressing hevin expression in a specific brain region leads to increased alcohol consumption.

BIOMOLECULES (2023)

Article Multidisciplinary Sciences

Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride

Jill Rocchetti, Caroline Fasano, Gregory Dal-Bo, Elisa Guma, Salah El Mestikawy, Tak-Pan Wong, Gohar Fakhfouri, Bruno Giros

Summary: Evidence suggests that excessive dopamine affects cognitive function in schizophrenia and antipsychotic drugs fail to improve cognitive deficits. Blocking D2 dopamine receptors leads to reshaping of mesohippocampal fibers, synaptic transmission deficits, and impairments in learning and memory. It is currently unknown how excessive dopamine affects hippocampal-related cognitive functions and the impact of antipsychotic drugs on hippocampal functions in this state.

PLOS ONE (2023)

Article Psychiatry

Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain

Alejandro Orrico-Sanchez, Bruno P. Guiard, Stella Manta, Jacques Callebert, Jean-Marie Launay, Franck Louis, Antoine Paccard, Carole Gruszczynski, Catalina Betancur, Vincent Vialou, Sophie Gautron

Summary: This study provides the first evidence of the physiological relevance of OCT2-mediated tryptophan transport and its biological consequences on serotonin homeostasis in the brain and SSRI efficacy.

TRANSLATIONAL PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study

Pei-Yang Gao, Ya-Nan Ou, Yi-Ming Huang, Zhi-Bo Wang, Yan Fu, Ya-Hui Ma, Qiong-Yao Li, Li-Yun Ma, Rui-Ping Cui, Yin-Chu Mi, Lan Tan, Jin-Tai Yu

Summary: Liver function may play a role in the progression of Alzheimer's disease. The study found that as AD progressed, certain liver function markers increased while others decreased. The relationship between liver function and CSF AD biomarkers indicates a potential mediation effect on cognition.

JOURNAL OF NEUROCHEMISTRY (2024)